Wellington Partners logo

Wellington Partners

Europe, Bayern, Germany, Munich

Description

Wellington Partners is a venture capital firm that invests in technology and life sciences companies.

Investor Profile

Wellington Partners has made 244 investments, with 7 in the past 12 months and 31% as lead.

Stage Focus

  • Series A (30%)
  • Series B (22%)
  • Series Unknown (14%)
  • Series C (11%)
  • Seed (10%)
  • Series D (8%)
  • Series E (2%)
  • Private Equity (2%)
  • Post Ipo Equity (1%)

Country Focus

  • Germany (35%)
  • United States (20%)
  • United Kingdom (13%)
  • France (8%)
  • Switzerland (5%)
  • Sweden (5%)
  • Denmark (3%)
  • Finland (2%)
  • Austria (2%)
  • Belgium (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Software
  • Medical Device
  • Therapeutics
  • Mobile
  • Manufacturing
  • Information Technology
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wellington Partners frequently co-invest with?

HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 8
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 7
Earlybird Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 8
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 9
b2venture
Europe, Berlin, Germany, Berlin
Co-Investments: 9
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 11
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 8
OpenOcean
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 7
Balderton Capital
Europe, England, United Kingdom, London
Co-Investments: 9
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 7

Which angels does Wellington Partners often collaborate with?

BH
Europe, England, United Kingdom, London
Shared Deals: 2
DA
Europe, Windsor and Maidenhead, United Kingdom, Windsor
Shared Deals: 1
JY
North America, California, United States, San Francisco
Shared Deals: 2
EJ
Europe, Ile-de-France, France, Paris
Shared Deals: 2
SC
Europe, England, United Kingdom, London
Shared Deals: 2
AM
North America, California, United States, San Francisco
Shared Deals: 1
FN
North America, California, United States, Menlo Park
Shared Deals: 1
GK
North America, Nevada, United States, Crystal Bay
Shared Deals: 1
LM
North America, California, United States, Menlo Park
Shared Deals: 3
PR
Europe, England, United Kingdom, London
Shared Deals: 2

What are some of recent deals done by Wellington Partners?

Aignostics

Berlin, Berlin, Germany

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningSoftware
Series BOct 29, 2024
Amount Raised: $34,000,000
CorFlow Therapeutics

Baar, Zug, Switzerland

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

BiotechnologyManufacturingMedicalMedical Device
Series BSep 10, 2024
Amount Raised: $48,489,444
Sphingotec GmbH

Hohen Neuendorf, Brandenburg, Germany

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Biotechnology
Series CAug 8, 2024
Amount Raised: $5,469,089
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
SciRhom

Martinsried, Bayern, Germany

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

BiotechnologyHealth Care
Series AJul 9, 2024
Amount Raised: $68,190,674
UroMems

Grenoble, Rhone-Alpes, France

UroMems is an innovative medtech company.

Health CareMedicalMedical Device
Series CJun 25, 2024
Amount Raised: $47,233,106
Seamless Therapeutics

Dresden, Sachsen, Germany

Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.

GeneticsTherapeutics
SeedApr 23, 2024
Amount Raised: $12,628,776
Onward

Eindhoven, Noord-Brabant, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

BiotechnologyHealth CareMachinery ManufacturingMedicalMedical DeviceTherapeutics
Post Ipo EquityMar 20, 2024
Amount Raised: $21,875,113
MMI

Pisa, Toscana, Italy

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Health CareMedicalMedical DeviceRobotics
Series CFeb 21, 2024
Amount Raised: $110,000,000
Minervax

Hellerup, Hovedstaden, Denmark

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

BiotechnologyHealth CareLife ScienceMedicalWellness
Series UnknownOct 11, 2023
Amount Raised: $57,367,288